Phase I Open-Label, Ascending Dose Trial Of Agen1884, An Anti-Ctla-4 Monoclonal Antibody, In Advanced Solid Malignancies: Dose Selection For Combination With Pd-1 Blockade.Breelyn A. Wilky,Priya Kumthekar,Robert Wesolowski,Jimmy J. Hwang,Steven I. Park,Igor Proscurshim,Guojun Yuan,Christopher D Dupont,Olga Shebanova,Jean-Marie Cuillerot, Edward Dow,Jeffrey Raizer,Carleen Gentry, Ainsley Ross,Elise Drouin,Nicholas S. Wilson,John M. Goldberg,Jennifer Buell,Robert Benjamin SteinJOURNAL OF CLINICAL ONCOLOGY（2018）引用 2|浏览40暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
